AMERICAN INTERNATIONAL GROUP, INC. - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 60 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$23,274
-57.2%
21,751
+3.7%
0.00%
Q2 2023$54,333
-31.8%
20,978
+7.5%
0.00%
-100.0%
Q1 2023$79,609
-17.1%
19,512
+2.0%
0.00%0.0%
Q4 2022$96,002
-61.1%
19,124
+1.3%
0.00%
-50.0%
Q3 2022$247,000
+5.1%
18,874
+2.8%
0.00%0.0%
Q2 2022$235,000
-1.7%
18,351
+17.3%
0.00%
+100.0%
Q1 2022$239,000
-19.5%
15,643
-6.6%
0.00%0.0%
Q4 2021$297,000
-18.0%
16,744
-2.9%
0.00%
-50.0%
Q3 2021$362,000
+4.0%
17,245
-2.3%
0.00%
+100.0%
Q2 2021$348,000
-20.2%
17,655
+17.7%
0.00%
-50.0%
Q1 2021$436,000
+3.8%
14,995
+8.2%
0.00%0.0%
Q4 2020$420,000
+85.0%
13,861
-2.8%
0.00%
+100.0%
Q3 2020$227,000
-19.8%
14,259
-0.7%
0.00%0.0%
Q2 2020$283,000
+59.0%
14,357
-0.7%
0.00%0.0%
Q1 2020$178,000
-37.1%
14,455
-5.5%
0.00%0.0%
Q4 2019$283,000
+371.7%
15,289
+254.3%
0.00%
Q3 2019$60,000
-4.8%
4,315
+0.9%
0.00%
Q2 2019$63,0004,2770.00%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Column Group LLC 18,136,735$232,513,00049.48%
Ponoi II Management, LLC 1,298,908$16,652,00045.25%
Ponoi Management, LLC 1,298,908$16,652,00026.29%
Euclidean Capital LLC 746,674$9,572,0008.14%
StepStone Group LP 1,573,357$20,170,0002.16%
First Light Asset Management, LLC 1,135,884$14,562,0001.69%
Lexington Partners L.P. 110,428$1,416,0000.73%
Rubric Capital Management LP 797,588$10,225,0000.54%
Boxer Capital, LLC 500,000$6,410,0000.41%
DAFNA Capital Management LLC 107,653$1,380,0000.38%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders